Clinical Trial

Assessment of DOT Spectacles in Chinese Children

Study acronym: CATHAY
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-09-28; most recent amendment 2026-07-09.
Status change: Recruiting → Active, Not Recruiting 2023-11-21
Status change: Not Yet Recruiting → Recruiting 2023-04-10
Trial Details
NCT Number NCT05562622
Lead Sponsor SightGlass Vision, Inc.
Conditions Juvenile Myopia, Myopia
Enrollment 195 participants
Start Date 2023-02-05
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-13